KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Return on Equity: 2011-2015

Historic Return on Equity for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to -0.60%.

  • Biocryst Pharmaceuticals' Return on Equity fell 12.00% to -0.60% in Q3 2015 from the same period last year, while for Sep 2015 it was -0.60%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -1.36% for FY2014, which is 4617.00% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Return on Equity of -0.60% as of Q3 2015, which was down 3.82% from -0.58% recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Return on Equity ranged from a high of 21.83% in Q1 2013 and a low of -31.00% during Q4 2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Return on Equity had a median value of -0.58% in 2015 and averaged 1.63%.
  • Over the last 5 years, Biocryst Pharmaceuticals' Return on Equity had its largest YoY gain of 3,036bps in 2014, and its largest YoY loss of 1,436bps in 2014.
  • Biocryst Pharmaceuticals' Return on Equity (Quarterly) stood at -2.34% in 2011, then reached -2.23% in 2012, then soared by 848bps to -31.00% in 2013, then skyrocketed by 3,036bps to -0.64% in 2014, then dropped by 12bps to -0.60% in 2015.
  • Its last three reported values are -0.60% in Q3 2015, -0.58% for Q2 2015, and -0.82% during Q1 2015.